Cite

HARVARD Citation

    Khalid, M. et al. (2018). Cardiovascular Side Effects of Tyrosine Kinase Inhibitor Ibrutinib (Imbruvica) and Interaction With Direct Oral Anticoagulant. American journal of therapeutics. p. . [Online]. 
  
Back to record